Matthew Perrone

Matthew Perrone, AP Health Writer

Page 2 of 7

NEW YORK, NEW YORK – DECEMBER 12: Dr. Marty Makary speaks during a screening of the HBO documentary film ‘Bleed Out’ on December 12, 2018 in New York City. (Photo by Noam Galai/Getty Images for HBO)

Trump taps a Fox News personality, a surgeon and a former congressman to lead public health agencies

By Matthew Perrone, Amanda Seitz, and others

This combination of images from video shows scenes from Nasonex television commercials broadcast in the U.S. in the 2000s. (AP Photo)

FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them

By Matthew Perrone and The Associated Press

Health officials are investigating an E. coli outbreak that has sickened people in 13 states. (AP Digital Embed)

McDonald’s E. coli case count grows as FDA investigators identify an ‘onion grower of interest’ in Washington

By Matthew Perrone and The Associated Press

FILE – A U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md., on Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File)

Thousands of drug plants have gone uninspected by the FDA since 2019

By Matthew Perrone, Nicky Forster, and others

FDA sign

FDA rejects psychedelic drug MDMA as a treatment for PTSD

By Matthew Perrone and The Associated Press

Casey Tylek

Veterans with PTSD are pushing for psychedelic drug therapy

By Matthew Perrone and The Associated Press

Man smoking E-cigarette. Monfalcone, Italy.

FDA OKs first menthol e-cigarettes, drawing criticism from parent groups who say the agency has ‘failed American families’

By Matthew Perrone and The Associated Press

FILE – A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, June 10, 2024, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. (AP Photo/Darron Cummings, File)

Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers

By Matthew Perrone and The Associated Press

Laurie Margolies

‘Some of the AI techniques are so good, frankly, I think we should be doing them now’: Some doctors welcome their new tech overlords

By Matthew Perrone and The Associated Press

Menthol cigarettes

Biden backs off long-awaited ban on menthol cigarettes

By Matthew Perrone, Zeke Miller, and others

FDA

FDA moves to bring multibillion-dollar medical test industry under full government scrutiny

By Matthew Perrone and The Associated Press

Philips

Philips to settle hundreds of defective sleep apnea machine lawsuits for $1.1 billion

By Matthew Perrone and The Associated Press

FILE – This image provided by Amylyx Pharmaceuticals shows the drug Relyvrio. The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday, April 4, 2024 it will pull the medicine from the U.S. market, acknowledging it didn’t help patients with the deadly neurological condition. (Amylyx Pharmaceuticals via AP)

ALS drug will be pulled from US market after study showed patients didn’t benefit

By Matthew Perrone and The Associated Press

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. (Photo by Cristina Arias/Cover/Getty Images)

FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug

By Tom Murphy, Matthew Perrone, and others

Top View of Unidentified Young Woman, Dressed in a Pink Pajama, holding her Contraceptive Pills, While She Is Standing in the Bathroom

First over-the-counter birth control pill in U.S. begins shipping to stores

By Matthew Perrone and The Associated Press